Publications in collaboration with researchers from University of Minnesota (18)

2024

  1. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

    Brain, Behavior, and Immunity, Vol. 121, pp. 192-210

  2. Correction to: SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex (Acta Neuropathologica Communications, (2022), 10, 1, (180), 10.1186/s40478-022-01480-y)

    Acta Neuropathologica Communications

2023

  1. Spatial organization of neuron-astrocyte interactions in the somatosensory cortex

    Cerebral cortex (New York, N.Y. : 1991), Vol. 33, Núm. 8, pp. 4498-4511

2022

  1. Astrocyte-neuronal network interplay is disrupted in Alzheimer's disease mice

    GLIA, Vol. 70, Núm. 2, pp. 368-378

  2. Omphalitis and Concurrent Serious Bacterial Infection

    Pediatrics, Vol. 149, Núm. 5

  3. SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

2021

  1. Dysregulation of astrocyte–neuronal communication in Alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 15

  2. Invasive bacterial infections in afebrile infants diagnosed with acute otitis media

    Pediatrics, Vol. 147, Núm. 1

  3. Neonatal mastitis and concurrent serious bacterial infection

    Pediatrics, Vol. 148, Núm. 1

  4. Pro-arrhythmogenic effects of Trypanosoma cruzi conditioned medium proteins in a model of bovine chromaffin cells

    Parasitology, Vol. 148, Núm. 13, pp. 1612-1623

2020

  1. Micromolar concentrations of Zn2+ depress cellular excitability through a blockade of calcium current in rat adrenal slices

    Toxicology, Vol. 444

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2014

  1. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

    Diabetes Technology and Therapeutics

  2. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

    Nature Genetics, Vol. 46, Núm. 9, pp. 989-993

2013

  1. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials

    The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915

2006

  1. Manipulating Kv4.2 identifies a specific component of hippocampal pyramidal neuron A-current that depends upon Kv4.2 expression

    Journal of Neurochemistry, Vol. 99, Núm. 4, pp. 1207-1223

1996

  1. Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: Modulation by the mesencephalic dopamine pathway via D1-subtype of receptor

    Neuroscience, Vol. 74, Núm. 1, pp. 51-66